Arvinas (ARVN) Amortizatization of Intangibles (2017 - 2026)
Arvinas (ARVN) recorded quarterly Amortizatization of Intangibles of $400000.0 in Q1 2026, down 83.33% quarter-over-quarter from $2.4 million in Q4 2025, and down 89.47% on a YoY basis from $3.8 million in Q1 2025.
Arvinas (ARVN) Amortizatization of Intangibles (2017 - 2026) Analysis & Trends
Arvinas' Amortizatization of Intangibles history runs 10 years deep, the most recent figure standing at $400000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 89.47% year-over-year to $400000.0; the TTM figure through Mar 2026 stood at $9.4 million (down 62.55% YoY), while the FY2025 annual figure was $12.8 million, down 41.28% from the prior year.
- Amortizatization of Intangibles was $400000.0 for Q1 2026 at Arvinas, down from $2.4 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $10.7 million in Q2 2024 to a low of -$7.2 million in Q4 2022.
- Historically, Amortizatization of Intangibles has averaged $1.8 million across 5 years, with a median of $2.4 million in 2025.
- Biggest YoY gain for Amortizatization of Intangibles was 2333.33% in 2022; the steepest drop was 500.0% in 2022.
- A 5-year view of Amortizatization of Intangibles shows it stood at -$7.2 million in 2022, then soared by 106.94% to $500000.0 in 2023, then jumped by 840.0% to $4.7 million in 2024, then plunged by 48.94% to $2.4 million in 2025, then sank by 83.33% to $400000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $400000.0 (Q1 2026), $2.4 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - | 400,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 400,000.00 |
| Mar 31, 2026 | 400,000.00 |
| Dec 31, 2025 | 2.40 Mn |
| Dec 31, 2025 | 2.40 Mn |
| Sep 30, 2025 | 3.10 Mn |
| Sep 30, 2025 | 3.10 Mn |
| Jun 30, 2025 | 3.50 Mn |
| Jun 30, 2025 | 3.50 Mn |
| Mar 31, 2025 | 3.80 Mn |
| Mar 31, 2025 | 3.80 Mn |
| Dec 31, 2024 | 4.70 Mn |
| Dec 31, 2024 | 4.70 Mn |
| Sep 30, 2024 | 5.90 Mn |
| Sep 30, 2024 | 5.90 Mn |
| Jun 30, 2024 | 10.70 Mn |
| Jun 30, 2024 | 10.70 Mn |
| Mar 31, 2024 | 500,000.00 |
| Mar 31, 2024 | 500,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Dec 31, 2023 | 500,000.00 |